A list of authorised orphan medicinal products registered by the UK licensing authority.
Similar Posts
Digital Health Technologies (DHTs) for Drug Development
Digital Health Technologies (DHTs) for Drug DevelopmentMHRA and NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies
Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.
CDER Center for Clinical Trial Innovation (C3TI)
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaborationCDER Data Standards Program
CDER Data Standards ProgramMHRA approves inavolisib for the treatment of breast cancer
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
Generic Drug User Fee Amendments
FDA is soliciting general comments on GDUFA II Program Fee: List of Abbreviated New Drug Application Sponsors and Application Numbers. The information gathered from public comments will assist FDA in accurately assessing FY 2018 GDUFA Program Fees in a timely manner.